Seth H. Z. Fischer
CIK 1573553 · Chief Executive Officer · last filed 2026-07-13
Seth H. Z. Fischer is a Chief Executive Officer who has filed 51 SEC Form 4 insider transactions across 8 companies since 2013. The most recent filing, for ESPR, was dated Jul 13, 2026. Across all open-market trades the lifetime net is −$43.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
8
51
-$43.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 0 | $3.18 | $0 | $0 | 7 | 2026-07-13 |
| MIST | Director | — | $1.07 | — | $0 | 5 | 2026-06-12 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 0 | $0.55 | $0 | -$6.7K | 11 | 2025-02-11 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 0 | $1.03 | $0 | -$55.4K | 6 | 2023-08-01 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 976 | $1.51 | $1.5K | $0 | 8 | 2023-06-09 |
| Streamex Corp. (BSGM) Delisted | Director | 6,000 | $6.35 | $38.1K | $0 | 1 | 2018-11-09 |
| VIVUS INC (VVUS) Delisted | Chief Executive Officer | 63,398 | — | — | $18.7K | 9 | 2018-01-03 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | — | — | — | $0 | 2 | 2013-05-23 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-13 | ESPR | Disp (D) | −141,023 | $0 | EDGAR |
| 2026-06-12 | MIST | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | ESPR | Grant (A) | +79,873 | $0 | EDGAR |
| 2025-06-12 | MIST | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | ESPR | Grant (A) | +33,000 | $0 | EDGAR |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Disp (D) | −15,007 | -$8.3K | EDGAR |
| 2024-08-29 | MIST | Grant (A) | — | $0 | EDGAR |
| 2024-08-26 | — | Disp (D) | −976 | -$1.5K | |
| 2024-06-20 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +2,300 | $0 | EDGAR |
| 2024-05-24 | ESPR | Grant (A) | +23,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.